Lamotrigin Medochemie (Lamotrigine)

Lamotrigine works by blocking voltage‑gated sodium channels on neurons, which reduces the rapid firing of nerve cells. This stabilises neuronal membranes and limits the release of excitatory neurotransmitters such as glutamate, helping to control seizures and mood swings.

The specific dose of lamotrigine is determined by the prescribing clinician based on the patient’s age, weight, renal and hepatic function, and the condition being treated. Dosage titration is individualized to achieve therapeutic benefit while minimising side effects.

Safety data for lamotrigine in pregnancy are limited and the drug is classified as pregnancy category unknown. Clinicians weigh potential benefits against risks, and if treatment is essential, close monitoring is advised. Lamotrigine does pass into breast milk, so breastfeeding decisions should be made with medical guidance.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Lamotrigine is distinguished by its broad spectrum activity against focal seizures and its mood‑stabilising properties, which many other anticonvulsants lack. Compared with drugs such as carbamazepine or valproate, lamotrigine generally has a lower risk of weight gain and sedation, but it requires careful titration to avoid skin reactions.

Lamotrigin Medochemie should be stored at room temperature, below 25 °C. Keep the tablets in the original packaging, protect them from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

The medication is taken orally, usually as a tablet, with or without food as directed by the prescriber. Swallow the tablet whole with water; do not crush, chew, or split it unless instructed, to ensure consistent absorption.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, which require immediate medical attention. Rare but critical adverse events may also involve blood dyscrasias and hepatic failure, underscoring the importance of prompt reporting of any unusual symptoms.

Lamotrigine is contraindicated in individuals with a known hypersensitivity to the drug or any of its components. Patients with a history of severe skin reactions to lamotrigine or related compounds should avoid it, and clinicians should assess suitability in those with significant hepatic or renal impairment.